<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000277243">
  <TermName>lonafarnib</TermName>
  <TermPronunciation>(loh-nah-FAR-nib)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An anticancer drug that belongs to the family of drugs called enzyme inhibitors. Also called SCH 66336.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000731225" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;lonafarnib&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000731224" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;lonafarnib&quot;" language="es" id="_4"/>
  <SpanishTermName>lonafarnib</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento contra el cáncer que es un tipo de inhibidor enzimático. También se llama SCH 66336.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-02-21</DateFirstPublished>
  <DateLastModified>2003-02-07</DateLastModified>
</GlossaryTerm>
